nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

29.08.2023 | Research

Prognostic analysis and treatment utilization of different treatment strategies in elderly esophageal cancer patients with distant metastases: a SEER database analysis

verfasst von: Lian-Qiang Han, Ting-Ting Cui, Nian-Jun Xiao, Wen Li

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 17/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to explore which therapeutic strategy is more beneficial for elderly esophageal cancer (EC) patients with distant metastasis, the treatment utilization status and the screening of factors related to prognosis, so as to better guide the treatment of these patients.

Methods

Patients in the Surveillance Epidemiology and End Results (SEER) database were divided into chemoradiotherapy (Group A), chemotherapy (Group B), radiotherapy (Group C), and no treatment (Group D) according to different treatment methods. Propensity score matching (PSM) was performed to adjust for baseline differences between the two groups. Overall survival (OS) and esophageal cancer-specific survival (ECSS) was calculated using the Kaplan–Meier method and compared using the log-rank test.

Results

A total of 7027 patients were included in this study, 5739 males (81.7%) and 1288 females (18.3%) with the median age was 70 (60–98). In the original cohort, the number of patients in the four groups was 2260 (Group A), 2087 (Group B), 945 (Group C) and 1735 (Group D), respectively. After PSM, there was no significant difference in mean OS (A vs B, 13.5 months VS 13.4 months, P = 0.511) and mean ECSS (A vs B, 15.6 vs 15.5 months, P = 0.374), while both OS (B vs C, 7 vs 3 months, P < 0.001) and ECSS (B vs C, 8 vs 3 months, P < 0.001) of chemotherapy alone were significantly better than those of radiotherapy alone. Subgroup analysis of patients older than 80 years showed that the median OS (A vs B, 7 vs 6 months) and median ECSS (A vs B, 8 vs 7 months) of Group A were significantly better than those of Group B (P < 0.05). In addition, all patients were randomly divided into a training set and a validation set with a ratio of 7:3. Based on the independent risk factors for OS, a nomogram model was constructed and validated.

Conclusion

For elderly EC patients with distant metastasis, aggressive treatment was still necessary after a comprehensive assessment of the patient's physical condition, especially for patients over 80 years old, and chemoradiotherapy maybe still the first choice. In addition, a nomogram model was constructed to intuitively and accurately evaluate the prognosis of this population.

Nur mit Berechtigung zugänglich

Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS et al (2019) Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology [in Eng]. J Natl Compr Canc Netw 17(7):855–883. https://doi.org/10.6004/jnccn.2019.0033CrossRefPubMed

Chen F, Luo H, Xing L, Liang N, Xie J, Zhang J (2018) Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: experience of two centers [in Eng]. Thorac Cancer 9(1):59–65. https://doi.org/10.1111/1759-7714.12536CrossRefPubMed

Chen Y, Cheng X, Song H, Wu AJ, Ku GY, Lee P, Slingerland M et al (2019) Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases [in Eng]. J Thorac Dis 11(4):1536–1545. https://doi.org/10.21037/jtd.2019.03.10CrossRefPubMedPubMedCentral

Deana C, Vetrugno L, Bignami E, Bassi F (2021) Peri-operative approach to esophagectomy: a narrative review from the anesthesiological standpoint [in Eng]. J Thorac Dis 13(10):6037–6051. https://doi.org/10.21037/jtd-21-940CrossRefPubMedPubMedCentral

Elimova E, Mizrak Kaya D, Harada K, Ajani JA (2016) Potentially curable cancers of the esophagus and stomach [in Eng]. Mayo Clin Proc 91(9):1307–1318. https://doi.org/10.1016/j.mayocp.2016.07.018CrossRefPubMed

Erkizan HV, Sukhadia S, Natarajan TG, Marino G, Notario V, Lichy JH, Wadleigh RG (2021) Exome sequencing identifies novel somatic variants in african american esophageal squamous cell carcinoma [in Eng]. Sci Rep 11(1):14814. https://doi.org/10.1038/s41598-021-94064-0CrossRefPubMedPubMedCentral

Guttmann DM, Mitra N, Bekelman J, Metz JM, Plastaras J, Feng W, Swisher-McClure S (2017) Improved overall survival with aggressive primary tumor radiotherapy for patients with metastatic esophageal cancer [in Eng]. J Thorac Oncol 12(7):1131–1142. https://doi.org/10.1016/j.jtho.2017.03.026CrossRefPubMed

Hong L, Huang YX, Zhuang QY, Zhang XQ, Tang LR, Du KX, Lin XY et al (2018) Survival benefit of re-irradiation in esophageal cancer patients with locoregional recurrence: a propensity score-matched analysis [in Eng]. Radiat Oncol 13(1):171. https://doi.org/10.1186/s13014-018-1122-yCrossRefPubMedPubMedCentral

Jain R, Yee JL, Shaikh T, Au C, Handorf E, Meyer JE, Dotan E (2020) Treatment-related toxicity and outcomes in older versus younger patients with esophageal cancer treated with neoadjuvant chemoradiation [in Eng]. J Geriatr Oncol 11(4):668–674. https://doi.org/10.1016/j.jgo.2019.06.014CrossRefPubMed

Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O et al (2019) Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1 [in Eng]. Esophagus 16(1):1–24. https://doi.org/10.1007/s10388-018-0641-9CrossRefPubMed

Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H et al (2015) Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society [in Eng]. Esophagus 12(1):1–30. https://doi.org/10.1007/s10388-014-0465-1CrossRefPubMed

Liang H, Peng H, Chen L (2021) Prognostic value of sarcopenia and systemic inflammation markers in patients undergoing definitive radiotherapy for esophageal cancer [in Eng]. Cancer Manag Res 13:181–192. https://doi.org/10.2147/cmar.S288522CrossRefPubMedPubMedCentral

Ma Z-H, Yang Y, Zou L, Luo K-Y (2012) 125i seed irradiation induces up-regulation of the genes associated with apoptosis and cell cycle arrest and inhibits growth of gastric Cancer xenografts [in Eng]. J Exp Clin Cancer Res CR 31(1):61. https://doi.org/10.1186/1756-9966-31-61CrossRefPubMed

Nagata Y, Yamamoto S, Kato K (2022) Immune checkpoint inhibitors in esophageal cancer: clinical development and perspectives [in Eng]. Hum Vaccin Immunother 18(6):2143177. https://doi.org/10.1080/21645515.2022.2143177CrossRefPubMedPubMedCentral

Ogawa H, Yajima T, Sohda M, Shirabe K, Saeki H (2021) Role of surgical resection and its alternative local therapy for pulmonary metastasis of colorectal cancer [in Eng]. Ann Gastroenterol Surg 5(6):747–753. https://doi.org/10.1002/ags3.12472CrossRefPubMedPubMedCentral

Qie S, Shi H, Wang F, Liu F, Gu J, Liu X, Li Y, Sun X (2022) Construction of survival prediction model for elderly esophageal cancer [in Eng]. Front Oncol 12:1008326. https://doi.org/10.3389/fonc.2022.1008326CrossRefPubMedPubMedCentral

Shirai K, Tamaki Y, Kitamoto Y, Murata K, Satoh Y, Higuchi K, Ishikawa H et al (2013) Prognosis was not deteriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy [in Eng]. J Radiat Res 54(4):706–711. https://doi.org/10.1093/jrr/rrt002CrossRefPubMedPubMedCentral

Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023 [in Eng]. CA Cancer J Clin 73(1):17–48. https://doi.org/10.3322/caac.21763CrossRefPubMed

Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D (2017) Oesophageal cancer [in Eng]. Nat Rev Dis Primers 3:17048. https://doi.org/10.1038/nrdp.2017.48CrossRefPubMedPubMedCentral

Suárez-Lledó A, Leiva-Badosa E, Llop-Talaveron JM, Fernández-Alvarez M, Farran-Teixidor L, Miró-Martín M, Virgili-Casas N et al (2021) Clinical, randomized, double blind clinical trial to study the effect of parenteral supplementation with fish oil emulsion in the nutritional support in esophagectomized patients [in Eng]. Medicine (baltimore) 100(25):e26426. https://doi.org/10.1097/md.0000000000026426CrossRefPubMed

Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X, Meng H et al (2017) Up-regulation of Lncrna Casc9 promotes esophageal squamous cell carcinoma growth by negatively regulating Pdcd4 expression through Ezh2" [in Eng]. Mol Cancer 16(1):150. https://doi.org/10.1186/s12943-017-0715-7CrossRefPubMedPubMedCentral

Wu Y, Chen J, Zhao L, Li Q, Zhu J, Yang H, Guo S, Xi M (2021) Prediction of pathologic response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma incorporating hematological biomarkers [in Eng]. Cancer Res Treat 53(1):172–183. https://doi.org/10.4143/crt.2020.594CrossRefPubMed

Zhai H, Huang Y, Li L, Zhang X, Yao J (2020) Mortality from heart disease following radiotherapy in esophageal carcinoma: a retrospective cohort study in US Seer Cancer Registry [in Eng]. Transl Cancer Res 9(4):2556–2564. https://doi.org/10.21037/tcr.2020.03.21CrossRefPubMedPubMedCentral

Zhang R, Jia M, Li P, Han J, Huang K, Li Q, Qiao Y et al (2019) Radiotherapy improves the survival of patients with metastatic esophageal squamous cell carcinoma: a propensity score matched analysis of surveillance, epidemiology, and end results database [in Eng]. Dis Esophagus. https://doi.org/10.1093/dote/doy074CrossRefPubMed

Zhao Q, Hu G, Xiao W, Chen Y, Shen M, Tang Q, Ning X (2017) Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: a retrospective cohort study [in Eng]. Medicine (baltimore) 96(35):e7920. https://doi.org/10.1097/md.0000000000007920CrossRefPubMed

Zhou S, Yang Y, Zhang Q, Zhu C, Cai P, Li D (2023) Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (Sib-Imrt) in 220 cases of locally advanced squamous esophageal cancer: a retrospective cohort study [in Eng]. Ann Transl Med 11(2):103. https://doi.org/10.21037/atm-22-6462CrossRefPubMedPubMedCentral

Titel: Prognostic analysis and treatment utilization of different treatment strategies in elderly esophageal cancer patients with distant metastases: a SEER database analysis
verfasst von: Lian-Qiang Han
Ting-Ting Cui
Nian-Jun Xiao
Wen Li
Publikationsdatum: 29.08.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 17/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-023-05260-6

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Prognostic analysis and treatment utilization of different treatment strategies in elderly esophageal cancer patients with distant metastases: a SEER database analysis

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 17/2023

Clinical research progress on BRAF V600E-mutant advanced colorectal cancer

A nomogram for predicting invasiveness of lung adenocarcinoma manifesting as pure ground-glass nodules: incorporating subjective CT signs and histogram parameters based on artificial intelligence

Machine learning and single-cell sequencing reveal the potential regulatory factors of mitochondrial autophagy in the progression of gastric cancer

Prediction of Fuhrman nuclear grade for clear cell renal carcinoma by a multi-information fusion model that incorporates CT-based features of tumor and serum tumor associated material

Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer

Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment—detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations

Neu im Fachgebiet Onkologie

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Update Onkologie